Marshall Wace Portfolio holdings
Marshall Wace is a British firm that runs long/short hedge funds. Its strategies combine computer-driven and traditional company analysis, applied worldwide and mostly to long/short equity. Paul Marshall, formerly head of European equities at Mercury Asset Management, and Ian Wace, formerly head of equities trading at Deutsche Bank, founded it in 1997. In 2002 it launched TOPS, a system that gathers investment ideas from equity professionals and uses algorithms to turn them into stock portfolios. In 2015 Marshall Wace formed a long-term partnership with KKR, a private equity and credit investor that took an ownership interest in the firm.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.9B |
| 2 |
Costco
COST
|
+$907M |
| 3 |
AbbVie
ABBV
|
+$643M |
| 4 |
JPMorgan Chase
JPM
|
+$609M |
| 5 |
Bank of America
BAC
|
+$567M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Mercado Libre
MELI
|
+$528M |
| 3 |
Broadcom
AVGO
|
+$514M |
| 4 |
Sandisk
SNDK
|
+$507M |
| 5 |
Marvell Technology
MRVL
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.91% |
| 2 | Technology | 20.64% |
| 3 | Consumer Discretionary | 9.07% |
| 4 | Healthcare | 8.21% |
| 5 | Financials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1701
Vishay Precision Group
VPG
$699M
| $2.54M | ﹤0.01% |
+16,933
| New | +$1.57M |
2026 Q2
0 quarters
|
|
1702
Janus Living Inc
JAN
$8.6B
| $2.54M | ﹤0.01% |
88,294
-147,397
| -63% | -$3.82M |
2026 Q1
1 quarter
|
|
1703
Unifirst Corp
UNF
$4.38B
| $2.54M | ﹤0.01% |
9,591
+5,191
| +118% | +$1.36M |
2025 Q1
5 quarters
|
|
1704
Ceragon Networks
CRNT
$223M
| $2.53M | ﹤0.01% |
976,612
+269,441
| +38% | +$705K |
2026 Q1
1 quarter
|
|
1705
Cohu
COHU
$2.12B
| $2.53M | ﹤0.01% |
34,209
-69,492
| -67% | -$3.47M |
2025 Q2
4 quarters
|
|
1706
BioCryst Pharmaceuticals
BCRX
$1.98B
| $2.53M | ﹤0.01% |
252,764
+6,287
| +3% | +$56.9K |
2026 Q1
1 quarter
|
|
1707
Aurora
AUR
$8.93B
| $2.52M | ﹤0.01% |
370,126
+359,726
| +3,459% | +$2.2M |
2025 Q3
3 quarters
|
|
1708
Pampa Energía
PAM
$3.35B
| $2.52M | ﹤0.01% |
30,706
-110,048
| -78% | -$9.17M |
2026 Q1
1 quarter
|
|
1709
CALL
Eli Lilly
LLY
$1.29T
| $2.52M | ﹤0.01% |
2,100
-400
| -16% | -$409K |
2025 Q2
4 quarters
|
|
1710
Disc Medicine
IRON
$3.93B
| $2.52M | ﹤0.01% |
+34,394
| New | +$2.36M |
2026 Q2
0 quarters
|
|
1711
Acadia Realty Trust
AKR
$2.78B
| $2.51M | ﹤0.01% |
+120,188
| New | +$2.57M |
2026 Q2
0 quarters
|
|
1712
Carter's
CRI
$1.28B
| $2.51M | ﹤0.01% |
60,979
-1,000,489
| -94% | -$37.9M |
2025 Q1
5 quarters
|
|
1713
Esquire Financial Holdings
ESQ
$1.61B
| $2.51M | ﹤0.01% |
21,059
-11,290
| -35% | -$1.25M |
2026 Q1
1 quarter
|
|
1714
Lakeland Industries
LAKE
$93M
| $2.51M | ﹤0.01% |
+234,575
| New | +$2.37M |
2026 Q2
0 quarters
|
|
1715
Strategic Education
STRA
$1.2B
| $2.51M | ﹤0.01% |
32,695
-108,356
| -77% | -$8.57M |
2025 Q3
3 quarters
|
|
|
HONA
1716
Honeywell Aerospace
HONA
$53.8B
| $2.5M | ﹤0.01% |
+11,312
| New | +$2.5M |
2026 Q2
0 quarters
|
|
1717
Pyxis Oncology
PYXS
$187M
| $2.5M | ﹤0.01% |
830,544
+476,127
| +134% | +$910K |
2025 Q4
2 quarters
|
|
|
1718
CALL
JPMorgan Chase
JPM
$913B
| $2.49M | ﹤0.01% |
7,600
+3,400
| +81% | +$1.06M |
2026 Q1
1 quarter
|
|
1719
Auna
AUNA
$338M
| $2.49M | ﹤0.01% |
484,566
-48,300
| -9% | -$244K |
2025 Q1
5 quarters
|
|
1720
MSG Knickerbockers Corp.
MSGK
$7.63B
| $2.48M | ﹤0.01% |
6,172
-93,020
| -94% | -$32.9M |
2024 Q2
8 quarters
|
|
1721
AMES National
ATLO
$306M
| $2.48M | ﹤0.01% |
83,618
+26,632
| +47% | +$770K |
2026 Q1
1 quarter
|
|
1722
SmartRent
SMRT
$326M
| $2.47M | ﹤0.01% |
2,073,922
-3,536,787
| -63% | -$4.49M |
2025 Q1
5 quarters
|
|
1723
ITT
ITT
$19.1B
| $2.46M | ﹤0.01% |
12,444
-156,090
| -93% | -$31.6M |
2026 Q1
1 quarter
|
|
1724
Erie Indemnity
ERIE
$14.3B
| $2.44M | ﹤0.01% |
+10,196
| New | +$2.34M |
2026 Q2
0 quarters
|
|
1725
Domino's
DPZ
$11B
| $2.44M | ﹤0.01% |
+8,247
| New | +$2.71M |
2026 Q2
0 quarters
|
|
Similar funds
Marshall Wace's Q2 2026 Portfolio in Review
As of Q2 2026, Marshall Wace held 3,898 positions worth $127B, up 26% from $100B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Marshall Wace deployed $9.28B of net new capital in Q2 2026, opening 771 new positions and adding to 1,083 existing holdings. Its largest new stake was LPL Financial: 975,627 shares worth $275M.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $1.03B trimmed.
- Marshall Wace's largest Q2 2026 buy was LPL Financial: 975,627 shares worth $275M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.9B increase.
- Marshall Wace's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.03B.
- Marshall Wace fully exited Merck in Q2 2026, selling an estimated $325M.
- Marshall Wace's ten largest holdings make up 38% of its $127B portfolio in Q2 2026.
- Marshall Wace opened 771 new positions and closed 795 in Q2 2026.
- Marshall Wace's portfolio value rose 26% quarter-over-quarter to $127B.
Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.